NCT00487656 - Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation | Biotech Hunter

Enrollment

750

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

August 31, 2010

Conditions

SepsisDisseminated Intravascular Coagulation

Interventions

DRUG

ART-123

6mg/ml ampule solution for injection @ .01mg/kg

DRUG

placebo

6 mg/ml ampule solution for injection at .01mg/kg

Trial Locations (62)

Unknown

Birmingham

Phoenix

Tuscon

Bakersfield

Colton

Loma Linda

Long Beach

Los Angeles

Rancho Mirage

San Diego

San Francisco

Stanford

Hartford

Bay Pines

Celebration

Jacksonville

Miami

Orlando

Atlanta

Augusta

Springfield

Kansas City

Topeka

Hazard

Louisville

Shreveport

Springfield

Ann Arbor

Kalamazoo

Pontiac

Camden

Englewood

Newark

Flushing

Durham

Fayetteville

Winston-Salem

Akron

Cincinnati

Cleveland

Columbus

Kettering

Toledo

Danville

Pittsburgh

Columbia

Knoxville

Houston

Lackland Air Force Base

Edmonton

Victoria

Kingston

London

Oshawa

Ottawa

Windsor

Greenfield Park

Kuala Pahang

Lumpur

Sarawak

Chiang Mai

Nakhonratchasima